Schwartz Aharon

Protalix BioTherapeutics, Inc. · Director

Schwartz Aharon is listed in public filings as director. This Schwartz Aharon insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Protalix BioTherapeutics, Inc. (PLX). Investors use Schwartz Aharon's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Protalix BioTherapeutics, Inc.PLX$206k129k sharesBuyJun 10, 2025$1.60--